The Movano Evie Ring - the women-focused smart ring that offered AI insights into how sleep, activity, and the menstrual cycle affect energy and mood - was one of 2023’s buzziest wearable tech stories.
It was unveiled at last year’s CES, then finally went on sale in January 2024. But the launch was, arguably, a disaster. Reviews slammed a lack of insights and features, buyers were left waiting for shipping, and many rings failed.
The Wareable Movano Evie Ring sample developed a fault – and the company pulled the ring off sale in March 2024.
But it’s coming back.
Evie Ring will go back on sale on 17 September 2024, with hardware and software changes that the company claims will turn around its fortunes.
But there’s more going on at Movano. As reported by Wareable last year, it’s working on an RF sensor that it believes could unlock non-invasive and cuffless blood pressure and glucose tracking from the finger.
Movano CEO, John Mastoratotoro, who led a team that developed the first continuous glucose monitor 25 years ago, talks to us about Evie Ring’s challenges, what it got right and wrong, its vision for its RF sensor, and bringing medical-grade devices to consumers.
In this PULSE Podcast episode:
03:08: Evie challenges – what went wrong
12:03: Relaunch, improvements, new insights
21:51: FDA Clearance
23:28: Evie Ring in medical trials and settings
33:02: Listening to women’s feedback
38:23: Building an RF sensor for blood glucose tracking and blood pressure monitoring
42:00: RF technology over optical HR for glucose tracking
45:00: Being a medical company launching consumer wearables
